/ RecruitingNot ApplicableIIT Safety and Efficacy of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma: Open Label Prospective Randomized Clinical Trial
The hypothesize that SBRT will limit or reverse tumor growth and thereby convert the borderline resectable disease or locally advanced disease in to a resectable tumor. Furthermore, we want to assess whether SBRT leads to an improved quality of life compared to IMRT.
100 Clinical Results associated with Capital Health System, Inc.
0 Patents (Medical) associated with Capital Health System, Inc.
100 Deals associated with Capital Health System, Inc.
100 Translational Medicine associated with Capital Health System, Inc.